DES MOINES — Iowa’s U.S. senators signaled opposition to a proposed plan from Senate Democrats aimed at lowering drug prices for Medicare recipients unveiled this week.
Sen. Joni Ernst and a spokesperson for Sen. Chuck Grassley, both Republicans, decried the plan as partisan in statements to the Lee Enterprises Des Moines Bureau.
…
This is a once in a generation chance for Democrats to finally deliver on their promises to lower drug prices. At a time when the price of everything is going up, this bill, if enacted, would finally rein in big Pharma’s price-gouging and make medicines more affordable for millions of Americans.
Washington, DC – Yesterday, Representative Susan Wild, a champion for cutting costs for the people of Pennsylvania’s Seventh District, sent a letter signed by 19 colleagues, calling for Senate Majority Leader Chuck Schumer and Senate Committee on Finance Chairman Ron Wyden to provide relief for Americans by taking action to lower prescription drug prices through a reconciliation bill.
…
Not only have Big Pharma corporations raised the prices of more than 450 drugs already this year, but this investigation from Senate Finance shows how they’re using complex loopholes to avoid paying taxes on the sales of those drugs.
It is absolutely ridiculous that at the same time Big Pharma is spending literally hundreds of millions of dollars to try and stop lawmakers from lowering prescription drug prices for families, they’re also raising prices of the most expensive drugs in the U.S. to inflate profits.
Congress is debating legislation right now that would lower drug prices, cap out-of-pocket costs and save American taxpayers hundreds of billions of dollars over the next decade.
The Florida Alliance for Retired Americans celebrated the 56th birthday of Medicare and Medicaid on Friday; the group is calling on Congress to lower prescription drug prices.
